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Fibronectin-binding proteins mediate Staphylococcus aureus internalization into nonphagocytic cells in vitro.
We have investigated whether fibronectin-binding proteins are virulence factors in the pathogenesis of pneu-
monia by using S. aureus strain 8325-4 and isogenic mutants in which fibronectin-binding proteins were either
deleted (DU5883) or overexpressed [DU5883(pFnBPA4)]. We first demonstrated that fibronectin-binding
proteins mediate S. aureus internalization into alveolar epithelial cells in vitro and that S. aureus internaliza-
tion into alveolar epithelial cells requires actin rearrangement and protein kinase activity. Second, we estab-
lished a rat model of S. aureus-induced pneumonia and measured lung injury and bacterial survival at 24 and
96 h postinoculation. S. aureus growth and the extent of lung injury were both increased in rats inoculated with
the deletion mutant (DU5883) in comparison with rats inoculated with the wild-type (8325-4) and the fibronec-
tin-binding protein-overexpressing strain DU5883(pFnBPA4) at 24 h postinfection. Morphological evaluation
of infected lungs at the light and electron microscopic levels demonstrated that S. aureus was present within
neutrophils from both 8325-4- and DU5883-inoculated lungs. Our data suggest that fibronectin-binding
protein-mediated internalization into alveolar epithelial cells is not a virulence mechanism in a rat model of
pneumonia. Instead, our data suggest that fibronectin-binding proteins decrease the virulence of S. aureus in
pneumonia.
In a recent survey, Staphylococcus aureus was found to be the
most common cause of lower respiratory tract infections in
Europe, the United States, Canada, Latin America, and the
Western Pacific region (9). In view of the fact that S. aureus
infections are increasingly difficult to treat because of the high
percentage of antibiotic-resistant strains (34), a better under-
standing of the molecular basis of S. aureus virulence in pneu-
monia may help in the design of new therapeutic strategies.
S. aureus has long been regarded as an extracellular patho-
gen because it is rarely observed inside cells in vivo and be-
cause it secretes a range of toxins that are cytolytic to many
host cell types (14, 29). However, recent in vitro studies dem-
onstrate that S. aureus is internalized and survives inside
nonphagocytic cells (1, 2, 12, 18, 19, 21). Fibronectin-binding
proteins present on the surface of S. aureus (16, 19, 26) medi-
ate internalization into nonphagocytic cells. S. aureus fibronec-
tin-binding proteins bind 1-integrins on the surface of the
host cells by means of a fibronectin bridge (16).
Survival of internalized S. aureus within nonphagocytic cells
may be an additional virulence mechanism in S. aureus infec-
tions (20). Internalized S. aureus may be able to evade or delay
elimination by the host’s immune system and avoid extracellu-
lar antibiotics (20). If internalization contributes to S. aureus
persistence in vivo, then drugs which interfere with fibronectin
binding to host cell integrins may have a role to play in treat-
ment of S. aureus infections (6).
Alveolar epithelial type I cells are large squamous cells that
cover over 95% of the lungs’ surface area; the remaining 5% is
covered by alveolar epithelial type II cells. Both alveolar epi-
thelial type I and II cells have a number of potential fibronec-
tin-binding receptors on their cell surfaces (7, 28, 32). The
overall objective of our study was to investigate whether fi-
bronectin-binding protein-mediated internalization into alveo-
lar epithelial cells is a virulence mechanism in S. aureus-in-
duced pneumonia.
MATERIALS AND METHODS
All reagents and materials were supplied by Sigma, Dorset, United Kingdom,
unless stated otherwise.
Bacteria. The S. aureus strains used in this study are derivatives of the wild-type
strain 8325-4. Strain DU5883 is an isogenic mutant of strain 8325-4 disrupted in the
fnbA (fnbA::Tcr) and fnbB (fnbB::Emr) genes (17). DU5883(pFnBPA4) is the dele-
tion mutant with fnbA expressed on a high copy plasmid (17). All strains were grown
overnight in Todd Hewitt broth (B. D. Biosciences, Oxford, United Kingdom);
DU5883(pFnBPA4) was selected with 10 g of chloramphenicol per ml. The iden-
tity of each S. aureus strain was regularly checked by using antibiotic disks (B. D.
Biosciences). Overnight cultures were washed twice with endotoxin-free phosphate-
buffered saline (PBS) before resuspension in PBS for all experiments.
Alveolar epithelial cell line. Simian virus 40 (SV40)-transformed strain AT2
neonatal alveolar epithelial cells were used for the in vitro internalization assays
(4). SV40-AT2 cells retain the sodium transport properties of alveolar type II
cells and express RTI40 (rat alveolar epithelial type I cell protein; molecular
mass, approximately 40 kDa) (25, 31). SV40-AT2 cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated
fetal calf serum (FCS) (Labtech International, East Sussex, United Kingdom),
penicillin (100 U/ml), and streptomycin sulfate (100 g/ml) (Invitrogen, Paisley,
United Kingdom). SV40-AT2 cells were maintained at 37°C in a 5% CO2 hu-
midified incubator (31). SV40-AT2 cells were prepared for internalization assays
by seeding semiconfluent 75-cm2 flasks onto six-well plates (Fred Baker Scien-
tific, Cheshire, United Kingdom) and incubating overnight in DMEM plus 10%
FCS.
Control SV40-AT2 cells were checked during the experimental period for
mycoplasmas by immunofluorescence staining with Hoechst 33258 DNA-binding
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dye (only the SV40-AT2 nuclei stained with the DNA-binding dye in mycoplas-
ma-negative cells) (38).
Internalization assay. Confluent SV40-AT2 cells were incubated for 1 h in
serum-free DMEM and then washed twice in PBS with calcium and magnesium.
DMEM (1 ml) containing 106 CFU of S. aureus per ml was added to each well
that contained SV40-AT2 cells (approximately 1.5  106 SV40-AT2 cells per
well). S. aureus was cocultured with SV40-AT2 cells for 2 to 6 h. At the end of
the coculture period, SV40-AT2 cells were washed twice with PBS and then
incubated for 1 h in the presence of gentamicin (100 g/ml in serum-free
DMEM). The SV40-AT2 cells were then washed three times with PBS and lysed
with 1% (wt/vol) NP-40 (ICN Biomedicals, Basingstoke, United Kingdom) in 10
mM Tris-HCl buffer, pH 8.0, containing 154 mM NaCl and complete protease
inhibitor cocktail (Roche Diagnostics, East Sussex, United Kingdom). The cell
lysate was diluted and plated out in triplicate on tryptic soy agar (TSA) plates
supplemented with sheep blood (B. D. Biosciences). The plates were incubated
overnight at 37°C, and the number of CFU was recorded to determine the
number of intracellular S. aureus. S. aureus CFU were only recovered in the
presence of SV40-AT2 cells.
Effects of cytochalasin D and genistein. The cytochalasin D and genistein assay
was a modification of the internalization assay described above. SV40-AT2 cells
were incubated for 1 h at 37°C with either cytochalasin D (2 M) or genistein
(250 M) (Roche Diagnostics) (18). Internalization assays were then performed
in the presence of inhibitors for 2 h at 37°C. At the end of the experimental
period, SV40-AT2 cells were washed and incubated with gentamicin. In some
experiments, washed SV40-AT2 cells were reincubated with S. aureus for an
additional 2 or 4 h to demonstrate that cytochalasin D and genistein were not
toxic to SV40-AT2 cells. The effects of cytochalasin D and genistein on the
number of internalized S. aureus were compared to the extent of S. aureus
internalized in the absence of inhibitors.
Pneumonia model. Male specific-pathogen-free rats (300 to 350 g) were ob-
tained from Harlan United Kingdom, Ltd. (Oxton, United Kingdom). Rats were
anaesthetized with an intraperitoneal injection of 1 ml of a mixture of Hypnorm
(0.315 mg of fentanyl citrate and 10 mg of fluanisone per ml) and Hypnoval (5
mg of midazolam hydrochloride per ml) (40). The rat’s mouth was opened, and
the trachea was visualized with the aid of a laryngoscope. A catheter (0.96 cm
external diameter, 9 cm in length) (Portex fine bore polyethylene tubing; Portex
Ltd., Kent, United Kingdom) was inserted into the distal airways. S. aureus
(approximately 108 CFU/0.5 ml) was instilled into the distal airways down the
catheter. PBS was instilled into the distal airways of control rats.
Experimental design. Lung tissue was obtained from rats inoculated with
8325-4 (n  3), DU5883 (n  3), or PBS (vehicle) (n  3) at 24 h postinfection
for analysis at the light microscopic level. For morphological analysis of lung
tissue at the electron microscopic level, lung tissue was obtained from rats
inoculated with 8325-4 (n  2), DU5883 (n  2), and PBS (n  2) at 24 h
postinfection. Bronchoalveolar lavage (BAL) fluid and lung tissue were obtained
from rats inoculated with 8325-4 at 24 h (n  7) and 96 h (n  5) postinfection;
from rats inoculated with DU5883 at 24 h (n 7) and 96 h (n 6) postinfection;
and from rats inoculated with DU5883(pFnBPA4) at 24 h (n  7) and 96 h (n 
5) postinfection. Control rats (PBS instilled) were also included at 24 h (n  7)
and 96 h (n  5). All animal experiments were carried out according to the
Animals (Scientific Procedures) Act, 1986.
Collection of lung tissue, blood, and BAL fluid samples. At the end of the
experimental period, rats were anaesthetized with pentobarbital (45 mg/kg in-
traperitoneally) containing heparin (500 U/kg intraperitoneally) (22–24). Blood
was collected from the ascending aorta. The trachea was canulated, and the lungs
were lavaged two times with sterile PBS. The lungs were then removed. BAL
fluid was centrifuged at 900  g for 5 min (23, 24). BAL fluid leukocytes were
quantified by hemacytometric counting. Differential cell counts on BAL fluid
cells were performed on cytocentrifuged preparations fixed with methanol and
stained with Diff-Quick. A total of 300 cells were counted per cytospin.
Protein assay. BAL fluid protein concentration was determined by using the
Bio-Rad assay (Bio-Rad Laboratories, Hertfordshire, United Kingdom) with
bovine serum albumin as a standard (Pierce Warriner, Chester, United King-
dom) (24). Data are expressed as the total amount of protein recovered in BAL
fluid (i.e., milligrams of protein per milliliter multiplied by the total volume of
BAL fluid recovered).
RTI40 assay. The amount of RTI40 (a biochemical marker for type I cell
damage) was measured in an enzyme-linked immunosorbent assay (ELISA)-
based assay essentially as described previously (22, 23). RTI40 was assayed on the
insoluble fraction of BAL fluid (500,000  gav for 10 min in a Beckman Optima
ultracentrifuge). Data are calculated as the total amount of RTI40 recovered in
BAL fluid (i.e., relative densitometry units of RTI40 per milliliter multiplied by
the total volume of BAL fluid) and then expressed as a percentage of the control
values.
Lung homogenates. Lungs were weighed and homogenized in Tris-HCl (2.42
mM)-buffered saline (TBS), pH 8.2, containing NaCl (154 mM) and proteinase
inhibitor cocktail (Roche Diagnostics). Lungs were homogenized by using a
blender (Ultra Turrax Y25; IKA-Werke) on ice at approximately 4,000 rpm twice
for 5 s each. Lung homogenates were serially diluted and plated out on blood
agar plates to determine the CFU.
Immunofluorescence analysis. Lungs were fixed with paraformaldehyde (4%
[wt/vol] in PBS) to determine the extent of alveolar epithelial necrosis in S.
aureus pneumonia at 24 h postinfection (24). Frozen lung sections (3 m) were
incubated with monoclonal antibodies (MAb) against alveolar epithelial type I
cells (anti-RTI40 MAb) (10) and two different MAb against alveolar epithelial
type II cells (anti-MMC4 antigen and anti-RTII70) (3) (11), followed by isotype-
specific secondary antibodies. Fluorescein isothiocyanate (FITC) conjugated to
anti-immunoglobulin G1 (IgG1) was used to detect the RTI40 protein (Lorne
Laboratories, Reading, United Kingdom) (3), Rhodamine-conjugated to anti-
IgG2a (Lorne Laboratories) was used to detect the MMC4 protein (3), and
Alexa Fluor 350 conjugated to anti-IgG3 was used to detect the anti-RTII70
antigen (Molecular Probes, Lieden, Netherlands). The nucleus was stained with
the DNA-binding dye Hoechst 33258. Immunofluorescence-stained sections
were observed by epifluorescence illumination (Axiovert S100; Zeiss). Images
were captured with a Cool Snap camera, and the images were processed by using
Improvision OpenLab software (version 2.2).
Gram stain. Paraffin sections were Gram stained to visualize S. aureus in lung
tissue at 24 h postinfection. Cytospun cells were also Gram stained to identify S.
aureus in neutrophils and macrophages from BAL fluid.
Electron microscopic analysis. Tissue samples for electron microscopy were
selected from the hemorrhaged region of lungs inoculated with either 8325-4 or
DU5883. Similar regions were taken from control lungs. Lung blocks were fixed
with glutaraldehyde buffer (3%) containing sodium cacodylate (0.1 M). Lung
blocks were postfixed in osmium tetroxide buffer (1%) containing sodium caco-
dylate (0.1 M). Lung blocks were then dehydrated in a graded series of alcohol
and embedded in polyethylene capsules in fresh Araldite epoxy resin. Lung
sections were cut and placed on 200-mesh uncoated grids and then stained with
uranyl acetate and lead citrate for electron microscopic studies. Sections were
viewed with a Philips CM12 electron microscope.
Statistical analysis. All data are expressed as means  standard error of the
mean. Data from the in vitro internalization assays were transformed to reflect
the total number of S. aureus recovered per well or transformed to fractions of
control values. Multiple sample means were compared by using one-way analysis
of variance with the Student-Newman-Keuls posttest.
Multiple sample means from data generated from the pneumonia models
(CFU, leukocyte numbers, and BAL protein and RTI40 concentrations) were
compared by using Kruskal-Wallis analysis of variance (nonparametric analysis
of variance), with Dunn’s multiple comparison posttest. P  0.05 was considered
significant. Tests were performed by using GraphPad InStat v3.00 for Windows
95 (www.graphpad.com).
RESULTS
Fibronectin-binding proteins are important for the internal-
ization of S. aureus by SV40-AT2 cells. The presence or absence
of fibronectin-binding proteins (Fig. 1) significantly affected the
extent of S. aureus internalization into SV40-AT2 cells. DU5883,
which does not express either FnBPA or -B, was internalized
20-fold less than 8325-4 (P  0.01). DU5883(pFnBPA4), which
overexpresses FnBPA, was internalized 2.4-fold more than 8325-4
(P  0.001) (Fig. 1). These data demonstrate that fibronectin-
binding proteins are important for internalization of S. aureus into
rat alveolar epithelial cells.
SV40-AT2 intracellular traffic is important for internaliza-
tion of S. aureus. S. aureus strain 8325-4 was cocultured with
SV40-AT2 cells for 2 h in the presence of inhibitors of intra-
cellular traffic (Fig. 2). Cytochalasin D, an inhibitor of actin
polymerization, reduced the extent of S. aureus internalization
by 91% (Fig. 2). Genistein, a protein tyrosine kinase inhibitor,
reduced internalization by 74% (P  0.01) (Fig. 2). The inhib-
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itors were not toxic to SV40-AT2 cells, since the extent of
internalization increased following the removal of these inhib-
itors from the incubation medium (Fig. 2).
Morphological changes to the lung in 8325-4-infected rats.
Distal airway instillation of 8325-4 into rat lungs induced pneu-
monia in the left lung in the majority of experiments. At au-
topsy, the involved lobe turned from red at 24 h postinfection
to grey at 96 h postinfection. Light microscopic analysis of lung
tissue at 24 h postinfection demonstrated that leukocytes had
filled the distal air spaces (Fig. 3C).
The morphological integrity of alveolar epithelial type I and
II cells in 8325-4-infected lungs was determined by immuno-
fluorescence analysis with the aid of cell-selective antibodies
(3, 10, 11). Type I cells were visualized with the aid of an
anti-RTI40 MAb (green staining) (Fig. 3 and 4). In control
lungs, the anti-RTI40 MAb bound to the apical surface of
alveolar epithelial type I cells (Fig. 3 and 4). In 8325-4-inocu-
lated lungs, the pattern and extent of anti-RTI40 binding were
similar to those in control lungs in most regions of the lung
(Fig. 3 and 4).
Alveolar epithelial type II cells were identified by using two
different MAbs. The anti-RTII70 MAb recognizes the apical
surface of type II cells (blue apical staining) (Fig. 4) (11), while
the MMC4 MAb recognizes the apical surface of alveolar
epithelial type II and Clara cells (red staining) (Fig. 4) (3). The
pattern and extent of both anti-type II MAb binding in 8325-
4-infected lungs 24 h postinfection were comparable to that in
control sections (Fig. 4). Occasionally, MMC4- and RTII70-
positive cells (type II cells) were rounded-up and appeared to
be in the process of shedding from their basement membranes
in 8325-4-infected lungs at 24 h postinfection (data not shown).
Effect of fibronectin-binding proteins on recovery of S. au-
reus in lung tissue and BAL fluid. The number of CFU recov-
ered in lung tissue 24 h postinfection decreased by over 97% in
rats inoculated with either 8325-4 or DU5883(pFnBPA4) in
comparison to the number of CFU instilled (Fig. 5). In con-
trast, the number of CFU recovered in lung tissue from
DU5883-inoculated rats was increased by 4.6-fold relative to
the instillate at 24 h postinfection (Fig. 5). Moreover, the
number of CFU recovered in DU5883-infected lungs at 24 h
was increased by over 190-fold relative to the number in 8325-
4-infected rats (P  0.05) and by 1,700-fold (P  0.01) in com-
parison to the number of CFU recovered from
DU5883(pFnBPA4)-infected lungs (Fig. 5). By 96 h postinfec-
tion, the number of CFU recovered from DU5883-inoculated
lungs was approaching the number of CFU obtained from both
8325-4- and DU5883(pFnBPA4)-inoculated lungs (Fig. 5).
In contrast to the lung data, the number of CFU recovered
in BAL fluid at 24 h was not significantly different between the
three S. aureus strains (Fig. 5). No CFU were recovered in
BAL fluid at 96 h postinfection in any of the S. aureus-infected
lungs.
Effect of fibronectin-binding proteins on leukocyte recruit-
ment to the lungs in pneumonia. The total number of leuko-
cytes recovered in BAL fluid from 8325-4-infected rats was
elevated 57-fold above control values at 24 h (Fig. 6A). At 24 h
postinfection, most of the leukocytes in BAL fluid from 8325-
4-infected rats were neutrophils (90%) (Fig. 6B). However, by
96 h postinfection the percentage of neutrophils had de-
creased, while that of both monocytes/macrophages and lym-
phocytes had increased (Fig. 6B).
The total number of leukocytes recovered in BAL fluid from
DU5883- and DU5883(pFnBPA4)-infected rats was signifi-
cantly elevated over control values, by 37-fold and 33-fold,
respectively (Fig. 6A). However, there were no significant dif-
ferences in the total number of leukocytes in BAL fluid be-
tween the different strains at either 24 or 96 h postinfection.
Nor was the percentage of neutrophils, macrophages/mono-
cytes, and lymphocytes recovered in BAL fluid significantly
different between S. aureus strains at either 24 or 96 h postin-
fection (data not shown).
Damage to the air-blood barrier in S. aureus pneumonia.
FIG. 1. Effect of fibronectin-binding proteins on S. aureus internal-
ization into alveolar epithelial cells. SV40-AT2 cells were cocultured
with either 8325-4, DU5883, or DU5883(pFnBP4) for 6 h. Extracellu-
lar S. aureus cells were killed with gentamicin. The experiment was
performed three times; data from one representative experiment are
shown. , P  0.01 versus control; , P  0.001 versus control.
FIG. 2. Effects of cytochalasin D and genistein on S. aureus inter-
nalization into alveolar epithelial cells. SV40-AT2 cells were cocul-
tured with 8325-4 in the presence of inhibitors for 2 h (black bars).
SV40-AT2 cells were then washed and reincubated for an additional
2 h or 4 h (diagonal stripes) in the presence of only S. aureus. The
extent of internalization was compared at each time point with that of
SV40-AT2 cells cultured with S. aureus alone. Data are presented as
the ratio of S. aureus internalized in the presence of inhibitor to S.
aureus internalized in the absence of inhibitor. The experiment was
performed twice with similar results. Data from one experiment are
shown. Both inhibitors significantly reduced the extent of 8325-4 in-
ternalization into SV40-AT2 cells in comparison to SV40-AT2 cells
cocultured with just 8325-4. , P  0.01 versus SV40-AT2 cells cocul-
tured with 8325-4.
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The amount of protein recovered in BAL fluid from 8325-4-
infected rats was elevated by 6.8-fold above control values at
24 h postinfection but by only 2.7-fold at 96 h postinfection
(Fig. 7A). The amount of protein recovered in BAL fluid from
DU5883-infected rats was significantly elevated over values
from both control and DU5883(pFnBPA4)-inoculated rats at
24 h postinfection (Fig. 7A). However, by 96 h postinfection,
the amount of protein recovered in BAL fluid was not signif-
icantly different between the three different strains (Fig. 7A).
To determine the extent of alveolar epithelial type I cell
necrosis in S. aureus pneumonia, the amount of RTI40 was also
measured in BAL fluid. The amount of RTI40 recovered in
BAL fluid from 8325-4- and DU5883(pFnBPA4)-infected rats
was not significantly different from control values (Fig. 7B).
However, the amount of RTI40 recovered from rats inoculated
with DU5883 was significantly elevated over both control and
DU5883(pFnBPA4)-infected rats at 24 h postinfection (Fig.
7B). There were no differences in the amount of RTI40 recov-
ered in BAL fluid from rats inoculated with S. aureus at 96 h
postinfection (data not shown).
Cellular location of S. aureus in 8325-4- and DU5883-in-
fected lungs. Gram stains of both BAL fluid cells (cytospins)
and infected lung tissue (paraffin sections) demonstrated that
S. aureus was predominantly associated with neutrophils from
infected rats (data not shown). In addition, the percentage of
neutrophils containing one or more Gram stain particles was
not different between 8325-4- and DU5883-infected lungs
(10.3  1.45 versus 11.8  6.08, respectively). Macrophages
occasionally contained a few gram-positive particles in their
cytoplasm. Gram-positive particles were very occasionally as-
FIG. 3. Immunofluorescence visualization of leukocyte influx and alveolar epithelium in S. aureus 8325-4-inoculated lungs at 24 h postinfection.
Alveolar epithelial type I cells were stained with the anti-RTI40 MAb (green), while alveolar epithelial type II cells were stained with the MMC4
MAb (red). Nuclei were stained with the Hoechst DNA-binding dye. (A) Phase-contrast image of control lung. (B) Corresponding immunoflu-
orescence image. (C) Phase-contrast image of 8325-4-inoculated lung. (D) Corresponding immunofluorescence image. Many of the air spaces
(stars) are filled with leukocytes ((Hoechst 33258-only-positive cells) in 8325-4-inoculated lungs in comparison with control lungs. Original
magnification, 100.
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sociated with the alveolar wall in both 8325-4- and DU5883-
infected lungs (data not shown). However, it was not possible
to resolve the location of the gram-positive particles by light
microscopy.
Electron microscopic analysis confirmed that neutrophils
from both 8325-4- and DU5883-infected lungs contained S.
aureus (Fig. 8A and B). Electron microscopic analysis of lung
tissue failed to demonstrate any S. aureus internalized with
alveolar epithelial cells in 8325-4-inoculated rats. However, S.
aureus was observed in one necrotic alveolar epithelial type II
cell from DU5883-inoculated rats (Fig. 8C and D).
DISCUSSION
We have demonstrated that S. aureus is internalized into rat
alveolar epithelial cells in vitro and that internalization is me-
diated by fibronectin-binding proteins located on the surface of
the bacteria. S. aureus internalization into alveolar epithelial
cells also requires an active cytoskeleton, since internalization
was inhibited by cytochalasin D, which disrupts actin struc-
tures. Furthermore, our data suggest that S. aureus internal-
ization is a regulated process, since the inhibition of tyrosine
kinases by genistein prevented uptake. Similar results have
been reported previously for S. aureus internalization into
other nonprofessional phagocytic cells, including mammary
gland epithelial cells, endothelial cells, and osteoblasts (1, 12,
15, 18, 24, 26).
To determine whether the expression of fibronectin-binding
proteins contributes to virulence in vivo, we first established a
rat model of S. aureus-induced pneumonia (strain 8325-4).
Instillation of S. aureus (108 CFU) into the distal airways of rat
lungs induced an acute inflammatory reaction that was resolv-
ing by 96 h postinfection. The total number of leukocytes and
the percentage of neutrophils in BAL fluid were both elevated
at 24 h postinfection but had returned to near control values at
96 h postinfection. Similarly, the amount of protein recovered
FIG. 4. High-magnification view of alveolar epithelium in S. aureus 8325-4-inoculated lungs at 24 h postinfection. Alveolar epithelial type I cells
were stained with the anti-RTI40 MAb (green, short arrows), and alveolar type II cells were stained with the MMC4 and anti-TII70 cell MAbs (red
and blue, respectively, long arrows). Nuclei were stained with the Hoechst DNA-binding dye. (A) Phase-contrast image of control lung.
(B) Corresponding immunofluorescent image. (C) Phase-contrast image of 8325-4-inoculated lung. (D) Corresponding immunofluorescent image.
Binding of alveolar cell-selective antibodies in 8325-4-infected lungs was not dissimilar from that in control lungs despite the ongoing inflammation.
Original magnification, 1,000.
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in BAL fluid, which is a measure of serum flux into the air
spaces, was elevated at 24 h but returned to near control levels
at 96 h postinfection. However, despite the elevated number of
leukocytes and protein in BAL fluid, our data did not reveal
major necrosis of alveolar epithelial type I cells in 8325-4-
induced pneumonia.
To determine whether fibronectin-binding proteins contrib-
ute to S. aureus virulence in pneumonia, we compared the
survival of three S. aureus strains. These three strains were the
wild-type 8325-4, a mutant (DU5883) in which both the fnbPA
and fnBPB genes were deleted, and the same mutant contain-
ing the gene for FnBPA on a high-copy-number plasmid
[DU5883(pFnBPA4)] (17). Contrary to what we expected, the
number of viable DU5883 cells in lung tissue at 24 h postin-
fection was 190-fold greater than the number of 8325-4 cells
and 1,700-fold greater than the number of DU5883(pFnBPA4)
cells. However, by 96 h postinfection, the number of viable
DU5883 S. aureus had declined to values approaching those of
both the wild type and the complemented mutant. These data
suggest that fibronectin-binding proteins promote S. aureus
elimination from the lungs.
The extent of acute lung injury, as measured by the total
amount of protein and RTI40 recovered in BAL fluid, was also
increased at 24 h postinfection in DU5883-infected rats in
comparison with values obtained from rats inoculated with
either the parental 8325-4 or the complemented mutant strain.
The amount of RTI40 in BAL fluid is associated with the extent
of morphological injury (necrosis) to alveolar epithelial cells in
other models of acute lung injury (22–24). It is possible that the
increased protein content of BAL fluid may represent in-
creased serum flux into the air spaces secondary to necrosis of
type I cells (22). Our data therefore suggest that the additional
S. aureus burden in DU5883-infected rats increased the sever-
ity of alveolar wall injury in comparison to 8325-4- and
DU5883 (pFnBPA)-inoculated lungs at 24 h postinfection.
Our data demonstrate that the absence of fibronectin-binding
proteins promotes alveolar wall injury in a rat model of S.
aureus pneumonia.
Many studies demonstrate that highly encapsulated forms of
bacterial pathogens, including S. aureus, are more virulent than
the weakly encapsulated forms (5, 35, 36). This difference in
virulence is thought to be due to the fact that encapsulated
forms are more resistant to internalization by both professional
(e.g., neutrophils) and nonprofessional (e.g., epithelial cells)
phagocytes in vivo (5, 35, 36). We have not determined why
strain DU5883 survives better in lung tissue than 8325-4 and
DU5883(pFnBPA4). Our data demonstrate that the number of
neutrophils recovered in BAL fluid at 24 h postinfection is not
significantly different among the three strains. Moreover, neu-
trophil recruitment to lung tissue, as measured by myeloper-
oxidase activity, was not significantly different between 8325-4-
and DU5883-infected lungs (unpublished observations).
Soluble fibronectin, which is present in BAL fluid, facilitates
neutrophil phagocytosis and killing of S. aureus in in vitro
assays (13, 30, 41). The fibronectin-binding protein-deficient S.
aureus strain may be less efficiently cleared by neutrophils in
comparison with fibronectin-binding protein-expressing strains
because it does not bind fibronectin. Alternatively, fibronectin
bound to fibronectin-binding protein-expressing strains of S.
aureus may enhance alveolar macrophage activation in com-
parison with the knockout mutant (39). We are currently in-
vestigating these two possibilities.
The exact the role of fibronectin-binding proteins in S. au-
reus virulence is unclear. On one hand, all of the clinical strains
of S. aureus tested so far contain one or both fibronectin-
binding protein genes (27). No S. aureus strains have been
identified which do not contain either of the fibronectin-bind-
ing protein genes (27). On the other hand, data from experi-
mental animal studies demonstrate that the expression of fi-
bronectin-binding proteins is not important for S. aureus
virulence and may in fact decrease the extent of virulence (8,
15; this study). Interestingly, adhesion of clinical strains of S.
aureus to fibronectin-coated slides is variable and does not
correlate with the number of fibronectin-binding protein genes
(27). Some methicillin-resistant S. aureus strains are also char-
acterized by their low adherence to fibronectin-coated slides
FIG. 5. Number of viable S. aureus recovered in lung tissue and BAL fluid at 24 and 96 h postinfection. The number of viable S. aureus (CFU)
was determined in lung tissue (black bars) and BAL fluid (horizontal bars). , P 0.01 versus instillate CFU; , P 0.001 versus instillate CFU;
#, P  0.05 versus 8325-4; ##, P  0.01 versus DU5883(pFnBPA4).
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(35). Low adherence of these methicillin-resistant S. aureus
strains is associated with the expression of a cell surface pro-
tein called Pls (plasmin sensitive) (33). It is possible that the
antivirulence effects of fibronectin-binding proteins may be
masked or modified during infection by the expression of an-
tiadhesion proteins such as Pls.
Integrin antagonists have been proposed as possible new
therapeutic agents to aid in the elimination of gram-positive
organisms by preventing fibronectin-binding protein-medi-
ated internalization into host cells (6). Our study suggests
that such drugs are unlikely to be useful in the treatment of
S. aureus-induced pneumonia. While we were able to detect
S. aureus within neutrophils at 24 h postinfection in rats
inoculated with strain 8325-4, we were not able to detect any
S. aureus internalized into alveolar epithelial cells. Our data
suggest that S. aureus internalization into alveolar epithelial
cells by a fibronectin-binding protein-mediated mechanism
is unlikely to be a virulence mechanism in our rat model of
pneumonia.
In summary, despite the fact that fibronectin-binding pro-
teins are widely expressed by S. aureus, our data suggest that
they reduce S. aureus virulence in a rat model of pneumonia.
Our data raise the possibility that anti-fibronectin-binding pro-
teins, such as Pls, may contribute to virulence by preventing S.
aureus internalization by both professional and nonprofes-
sional phagocytes.
FIG. 6. Number and profile of leukocytes recovered in BAL fluid
from S. aureus-inoculated lungs at 24 and 96 h postinfection. (A) Total
number of leukocytes recovered in BAL fluid from 8325-4-, DU5883-
and DU5883(pFnBPA4)-inoculated lungs. (B) Percentage of neutro-
phils (black bars), macrophages and monocytes (diagonally striped
bars), and lymphocytes (horizontally striped bars) in BAL fluid from
control and 8325-4-inoculated lungs. , P  0.05 versus control; , P
 0.01 versus control; , P  0.001 versus control.
FIG. 7. Amount of protein and RTI40 recovered in BAL fluid at 24
and 96 h postinfection. (A) The amount of protein recovered in BAL
fluid from 8325-4-, DU5883-, and DU5883(pFnBPA4)-inoculated rats
at 24 and 96 h postinfection. (B) The amount of RTI40 recovered in
BAL fluid at 24 h postinfection. , P 0.05 versus control; , P 0.01
versus control; , P  0.001 versus control; #, P  0.05 versus
DU5883(pFnBPA4); ##, P  0.01 versus DU5883(pFnBPA4).
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